Your Unread Messages
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians
Annals of Rheumatic Diseases, 10/23/09
Rueda B et al. – Our results suggest that BANK1 gene confers susceptibility to SSc in general, and specifically to the dcSSc and anti-topoisomerase-I antibody subsets.
Methods- Large multicenter case-control association study
- 2380 SSc patients and 3270 healthy controls from six independent case-control sets of Caucasian ancestry (American, Spanish, Dutch, German, Swedish and Italian)
- 3 putative functional BANK1 polymorphisms (rs17266594 T/C, rs10516487 G/A, rs3733197 G/A) selected as genetic markers and genotyped by Taqman 5'allelic discrimination assay
- Significant association of rs10516487 G and rs17266594 T alleles with SSc susceptibility observed whereas the rs3733197 genetic variant showed no statistically significant deviation
- Stratification for cutaneous SSc phenotype revealed BANK1 rs10516487 G, rs17266594 T, and rs3733197 G alleles were strongly associated with susceptibility to diffuse SSc (dcSSc)
- Stratification for specific SSc auto-antibodies showed association of BANK1 rs10516487, rs17266594, and rs3733197 polymorphisms was restricted to subgroup of patients carrying anti-topoisomerase I antibodies
Today in Autoimmune/Heritable...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjögrens syndrome
Arthritis & Rheumatism, 11/06/09
Lung involvement in patients with primary Sjögrens syndrome: What are the predictors?
Rheumatology International, 10/26/09
A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis
Rheumatology, 10/23/09
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Hepatoprotective effect of TNF-alpha blockade in psoriatic arthritis: A cross-sectional study
Annals of Rheumatic Diseases, 11/09/09
Musculoskeletal manifestations in patients with malignant disease
Clinical Rheumatology, 11/13/09
The relationship between synovial lymphocyte aggregates and the clinical response to infliximab in rheumatoid arthritis: A prospective study
Arthritis & Rheumatism, 11/04/09
Today in Connective Tissue Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Nephrogenic systemic fibrosis
Current Opinion in Rheumatology, 11/04/09
A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis
Rheumatology, 10/23/09
Comparison of injection methods in myofascial pain syndrome: A randomized controlled trial
Clinical Rheumatology, 10/27/09
Sponsor
Article Search
Sponsor


See All



